Word: astrazeneca
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...Phase II clinical trial with the experimental drug cediranib conducted several years ago showed that patients treated with the drug survived longer compared to historical controls. Researchers wanted to know why this occurred, said Tracy T. Batchelor, one of the authors of the study and a consultant to AstraZeneca Pharmaceuticals, which produces cediranib. “This was a bench to bedside and back to bench journey,” added Batchelor, referring to the return to the laboratory after the drug’s clinical trial. The researchers used rodent models with three different kinds of glioblastoma and placed...
...damning indictment was part of a 400-page, interim Commission report based on evidence collected during January raids at the headquarters to some of the world's biggest drug companies, including U.S. companies Pfizer and Johnson & Johnson, Britain's GlaxoSmithKline, Anglo-Swedish giant AstraZeneca, and Sanofi-Aventis of France. The other companies known to be raided were Wyeth, Merck, Bayer Schering Pharma and Roche, as well as generic firms Teva and Sandoz...
...According to the pharmaceutical market news service Pharmawire, around $114 billion worth of drugs will go off patent in 2008-12, including lucrative brands such as Eisai's Aricept, which treats Alzheimers, and Pfizer's Lipitor, which lowers cholesterol. Some analysts say patent expirations could lead AstraZeneca and GlaxoSmithKline to lose up to one third of their sales...
...Last fall, Grassley and Senator Herbert H. Kohl, a Wisconsin Democrat, introduced the Physician Payments Sunshine Act, which will require companies to report payments that they make to doctors. Legislation for the Sunshine Act, which has recently secured endorsements last month from pharmaceutical companies such as Eli Lilly, AstraZeneca, and Merck, is currently pending...
...Kroes said the probe was partly triggered by her 2005 fine on AstraZeneca of €60 million ($88m) after the Commission found the company had delayed market entry of a rival ulcer drug by misleading authorities over the expiration of its patent...